In response to TNFα, activated NFκB (nuclear factor- κB) directly binds to a specific constituent enhancer of CD47 and increases its gene expression in MCF-7 breast cancer cells resulting in tumor growth by inhibiting phagocytosis 28. This evidence concerns the gene CD47 and breast cancer.